These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 27549635)
21. Selection of N86F184D1246 haplotype of Pfmrd1 gene by artemether-lumefantrine drug pressure on Plasmodium falciparum populations in Senegal. Mbaye A; Dieye B; Ndiaye YD; Bei AK; Muna A; Deme AB; Yade MS; Diongue K; Gaye A; Ndiaye IM; Ndiaye T; Sy M; Diallo MA; Badiane AS; Ndiaye M; Seck MC; Sy N; Koita O; Krogstad DJ; Nwakanma D; Ndiaye D Malar J; 2016 Aug; 15(1):433. PubMed ID: 27562216 [TBL] [Abstract][Full Text] [Related]
22. Selection of known Plasmodium falciparum resistance-mediating polymorphisms by artemether-lumefantrine and amodiaquine-sulfadoxine-pyrimethamine but not dihydroartemisinin-piperaquine in Burkina Faso. Somé AF; Séré YY; Dokomajilar C; Zongo I; Rouamba N; Greenhouse B; Ouédraogo JB; Rosenthal PJ Antimicrob Agents Chemother; 2010 May; 54(5):1949-54. PubMed ID: 20231394 [TBL] [Abstract][Full Text] [Related]
23. In vivo selection of Plasmodium falciparum parasites carrying the chloroquine-susceptible pfcrt K76 allele after treatment with artemether-lumefantrine in Africa. Sisowath C; Petersen I; Veiga MI; Mårtensson A; Premji Z; Björkman A; Fidock DA; Gil JP J Infect Dis; 2009 Mar; 199(5):750-7. PubMed ID: 19210165 [TBL] [Abstract][Full Text] [Related]
24. Baseline in vivo, ex vivo and molecular responses of Plasmodium falciparum to artemether and lumefantrine in three endemic zones for malaria in Colombia. Aponte S; Guerra ÁP; Álvarez-Larrotta C; Bernal SD; Restrepo C; González C; Yasnot MF; Knudson-Ospina A Trans R Soc Trop Med Hyg; 2017 Feb; 111(2):71-80. PubMed ID: 28460112 [TBL] [Abstract][Full Text] [Related]
25. Increased prevalence of the Plasmodium falciparum Pfmdr1 86N genotype among field isolates from Franceville, Gabon after replacement of chloroquine by artemether-lumefantrine and artesunate-mefloquine. Lekana-Douki JB; Dinzouna Boutamba SD; Zatra R; Zang Edou SE; Ekomy H; Bisvigou U; Toure-Ndouo FS Infect Genet Evol; 2011 Mar; 11(2):512-7. PubMed ID: 21251998 [TBL] [Abstract][Full Text] [Related]
26. Temporal trends in prevalence of Plasmodium falciparum molecular markers selected for by artemether-lumefantrine treatment in pre-ACT and post-ACT parasites in western Kenya. Achieng AO; Muiruri P; Ingasia LA; Opot BH; Juma DW; Yeda R; Ngalah BS; Ogutu BR; Andagalu B; Akala HM; Kamau E Int J Parasitol Drugs Drug Resist; 2015 Dec; 5(3):92-9. PubMed ID: 26236581 [TBL] [Abstract][Full Text] [Related]
27. A randomized trial of artesunate-mefloquine versus artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Mali. Sagara I; Diallo A; Kone M; Coulibaly M; Diawara SI; Guindo O; Maiga H; Niambele MB; Sissoko M; Dicko A; Djimde A; Doumbo OK Am J Trop Med Hyg; 2008 Nov; 79(5):655-61. PubMed ID: 18981499 [TBL] [Abstract][Full Text] [Related]
28. Comparative efficacies of artemisinin combination therapies in Plasmodium falciparum malaria and polymorphism of pfATPase6, pfcrt, pfdhfr, and pfdhps genes in tea gardens of Jalpaiguri District, India. Saha P; Guha SK; Das S; Mullick S; Ganguly S; Biswas A; Bera DK; Chattopadhyay G; Das M; Kundu PK; Ray K; Maji AK Antimicrob Agents Chemother; 2012 May; 56(5):2511-7. PubMed ID: 22314538 [TBL] [Abstract][Full Text] [Related]
29. Assessment of the therapeutic efficacy of artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in northern KwaZulu-Natal: an observational cohort study. Vaughan-Williams CH; Raman J; Raswiswi E; Immelman E; Reichel H; Gate K; Knight S Malar J; 2012 Dec; 11():434. PubMed ID: 23272998 [TBL] [Abstract][Full Text] [Related]
30. Repeated treatment of recurrent uncomplicated Plasmodium falciparum malaria in Senegal with fixed-dose artesunate plus amodiaquine versus fixed-dose artemether plus lumefantrine: a randomized, open-label trial. Ndiaye JL; Faye B; Gueye A; Tine R; Ndiaye D; Tchania C; Ndiaye I; Barry A; Cissé B; Lameyre V; Gaye O Malar J; 2011 Aug; 10():237. PubMed ID: 21838909 [TBL] [Abstract][Full Text] [Related]
31. Efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for treatment of uncomplicated malaria in children in Zaire and Uíge Provinces, angola. Plucinski MM; Talundzic E; Morton L; Dimbu PR; Macaia AP; Fortes F; Goldman I; Lucchi N; Stennies G; MacArthur JR; Udhayakumar V Antimicrob Agents Chemother; 2015 Jan; 59(1):437-43. PubMed ID: 25367912 [TBL] [Abstract][Full Text] [Related]
32. Efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated malaria in Papua New Guinea. Tavul L; Hetzel MW; Teliki A; Walsh D; Kiniboro B; Rare L; Pulford J; Siba PM; Karl S; Makita L; Robinson L; Kattenberg JH; Laman M; Oswyn G; Mueller I Malar J; 2018 Oct; 17(1):350. PubMed ID: 30290825 [TBL] [Abstract][Full Text] [Related]
33. In Vivo Efficacy and Parasite Clearance of Artesunate + Sulfadoxine-Pyrimethamine Versus Artemether-Lumefantrine in Mali. Niaré K; Dara A; Sagara I; Sissoko MS; Guindo CO; Cissé NH; Coulibaly CO; Ringwald P; Benoit-Vical F; Berry A; Djimdé AA; Doumbo OK Am J Trop Med Hyg; 2016 Mar; 94(3):634-9. PubMed ID: 26811430 [TBL] [Abstract][Full Text] [Related]
34. Therapeutic efficacy and effect on gametocyte carriage of an artemisinin and a non-based combination treatment in children with uncomplicated P. falciparum malaria, living in an area with high-level chloroquine resistance. Okafor HU; Shu EN; Oguonu T J Trop Pediatr; 2010 Dec; 56(6):398-406. PubMed ID: 20144932 [TBL] [Abstract][Full Text] [Related]
35. A randomised controlled trial of artemether-lumefantrine versus artesunate for uncomplicated plasmodium falciparum treatment in pregnancy. McGready R; Tan SO; Ashley EA; Pimanpanarak M; Viladpai-Nguen J; Phaiphun L; Wüstefeld K; Barends M; Laochan N; Keereecharoen L; Lindegardh N; Singhasivanon P; White NJ; Nosten F PLoS Med; 2008 Dec; 5(12):e253. PubMed ID: 19265453 [TBL] [Abstract][Full Text] [Related]
36. K13 mutations and pfmdr1 copy number variation in Plasmodium falciparum malaria in Myanmar. Win AA; Imwong M; Kyaw MP; Woodrow CJ; Chotivanich K; Hanboonkunupakarn B; Pukrittayakamee S Malar J; 2016 Feb; 15():110. PubMed ID: 26911145 [TBL] [Abstract][Full Text] [Related]
37. Day 3 parasitemia and Plasmodium falciparum Kelch 13 mutations among uncomplicated malaria patients treated with artemether-lumefantrine in Adjumani district, Uganda. Angwe MK; Mwebaza N; Nsobya SL; Vudriko P; Dralabu S; Omali D; Tumwebaze MA; Ocan M PLoS One; 2024; 19(6):e0305064. PubMed ID: 38837973 [TBL] [Abstract][Full Text] [Related]
38. Efficacy and tolerability of artesunate-amodiaquine (Camoquin plus) versus artemether-lumefantrine (Coartem) against uncomplicated Plasmodium falciparum malaria: multisite trial in Senegal and Ivory Coast. Faye B; Offianan AT; Ndiaye JL; Tine RC; Touré W; Djoman K; Sylla K; Ndiaye PS; Penali L; Gaye O Trop Med Int Health; 2010 May; 15(5):608-13. PubMed ID: 20214761 [TBL] [Abstract][Full Text] [Related]
39. In Vitro and Molecular Surveillance for Antimalarial Drug Resistance in Plasmodium falciparum Parasites in Western Kenya Reveals Sustained Artemisinin Sensitivity and Increased Chloroquine Sensitivity. Lucchi NW; Komino F; Okoth SA; Goldman I; Onyona P; Wiegand RE; Juma E; Shi YP; Barnwell JW; Udhayakumar V; Kariuki S Antimicrob Agents Chemother; 2015 Dec; 59(12):7540-7. PubMed ID: 26392510 [TBL] [Abstract][Full Text] [Related]
40. The role of pfmdr1 in Plasmodium falciparum tolerance to artemether-lumefantrine in Africa. Sisowath C; Ferreira PE; Bustamante LY; Dahlström S; Mårtensson A; Björkman A; Krishna S; Gil JP Trop Med Int Health; 2007 Jun; 12(6):736-42. PubMed ID: 17550470 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]